« back to gallery

FIN_Nikon D1

Montreal, May 10, 2001<br />
Andre De Villers, M.D., President and CEO of Theratechnologies Inc. present his report at the company annual meeting, May 10 in Montreal, CANADA.<br />
Theratechnologies Inc is a Canadian biopharmaceutical company engaged in the fields of therapeuticc peptides and cell theraphy.<br />
One of their products ; Theralux (tm) has reached Phase I/II status in CML ans is at a pivotal stage in NHL, bringing this product closer to commercialization<br />
By the 2nd quater of 2002, Theratechnologies expect to fullfill all the requirements to be listed on Nasdaq.<br />
Photo by Pierre Roussel / Liaison<br />
NOTE:  Corrected Nikon D-1 JPEG opened as NTSC saved as Adobe RGB color space..
Share
twitterlinkedinfacebook
Theratechnologies
Montreal, May 10, 2001
Andre De Villers, M.D., President and CEO of Theratechnologies Inc. present his report at the company annual meeting, May 10 in Montreal, CANADA.
Theratechnologies Inc is a Canadian biopharmaceutical company engaged in the fields of therapeuticc peptides and cell theraphy.
One of their products ; Theralux (tm) has reached Phase I/II status in CML ans is at a pivotal stage in NHL, bringing this product closer to commercialization
By the 2nd quater...
more »

Filename: 0105_6551_Thera.jpg
From gallery: FIN_Nikon D1
Source: Images Distribution
Date: 8 Nov 2008
Location: Montreal Quebec Canada
Credit: Images Distribution
Copyright:
Model Release: No
Property Release: No
Restrictions: editorial only, No Sub-Agent, Dont send to Newscom
Direct Link:
Keywords: